In addition, cagrilintide is now being developed in combination with the GLP-1 agonist semaglutide as CagriSema to achieve sustained weight loss in persons with overweight and obesity
This story discusses eating disorders
Dangers of unlicensed weight loss products Unlicensed weight loss products have not undergone rigorous safety testing, and you cannot be sure of the ingredients or dosing 11
Whether it is the right option depends on your individual health circumstances, comfort with compounded versus FDA-approved medications, and personal preferences for how you receive healthcare
therefore, obesity is now considered to be a disease requiring treatment, rather than merely a cosmetic problem
Some report that taking semaglutide before bed may help manage nausea, a common side effect, by allowing them to sleep through the initial hours after injection